Business Description
Kintor Pharmaceutical Ltd
ISIN : KYG5273B1077
Share Class Description:
KNTPF: Ordinary SharesCompare
Compare
Traded in other countries / regions
09939.Hong KongKNTPF.USA IPO Date
2020-09-08Description
Kintor Pharmaceutical Ltd is a clinical-stage novel drug developer in China focused on the proprietary R&D of drugs for cancers and other AR-related diseases. The company's drug candidate, Pruxelutamide, is a drug undergoing phase III clinical trials in China and phase III clinical trials in the United States for mCRPC as well as clinical trials for breast cancer. Its pipeline of seven drug candidates includes Pruxelutamide (GT0918), Pyrilutamide (KX-826), ALK-1 (GT90001), Detorsertib (GT0486), Hedgehog/SMO Inhibitor (GT1708F), PD-L1/TGF-B (GT90008), and AR-PROTAC Compound (GT20029). The company operates in a single segment focusing on the research and development of medical products.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.79 | |||||
| Equity-to-Asset | 0.53 | |||||
| Debt-to-Equity | 0.55 | |||||
| Debt-to-EBITDA | -0.24 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -11.6 | |||||
| 3-Year EPS without NRI Growth Rate | -11.4 | |||||
| 3-Year FCF Growth Rate | 18.4 | |||||
| 3-Year Book Growth Rate | -38.6 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 87.89 | |||||
| 9-Day RSI | 78.15 | |||||
| 14-Day RSI | 71.57 | |||||
| 6-1 Month Momentum % | -56.13 | |||||
| 12-1 Month Momentum % | -76.71 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | |||||
| Quick Ratio | 2.1 | |||||
| Cash Ratio | 2.03 | |||||
| Days Inventory | 5382.89 | |||||
| Days Payable | 661.71 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.6 | |||||
| Shareholder Yield % | -3.35 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -96.14 | |||||
| ROA % | -65.73 | |||||
| ROIC % | -126.87 | |||||
| ROC (Joel Greenblatt) % | -200.46 | |||||
| ROCE % | -79.08 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.12 | |||||
| Price-to-Tangible-Book | 1.82 | |||||
| EV-to-EBIT | -0.29 | |||||
| EV-to-Forward-EBIT | -1.98 | |||||
| EV-to-EBITDA | -0.29 | |||||
| EV-to-Forward-Revenue | 1.98 | |||||
| EV-to-FCF | -0.78 | |||||
| Price-to-Net-Current-Asset-Value | 9.12 | |||||
| Price-to-Net-Cash | 9.12 | |||||
| Earnings Yield (Greenblatt) % | -344.83 | |||||
| FCF Yield % | -76.32 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:KNTPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kintor Pharmaceutical Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.346 | ||
| Beta | -1.31 | ||
| Volatility % | 79.91 | ||
| 14-Day RSI | 71.57 | ||
| 14-Day ATR ($) | 0.003672 | ||
| 20-Day SMA ($) | 0.1648 | ||
| 12-1 Month Momentum % | -76.71 | ||
| 52-Week Range ($) | 0.1 - 0.6123 | ||
| Shares Outstanding (Mil) | 447.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kintor Pharmaceutical Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kintor Pharmaceutical Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kintor Pharmaceutical Ltd Frequently Asked Questions
What is Kintor Pharmaceutical Ltd(KNTPF)'s stock price today?
The current price of KNTPF is $0.18. The 52 week high of KNTPF is $0.61 and 52 week low is $0.10.
When is next earnings date of Kintor Pharmaceutical Ltd(KNTPF)?
The next earnings date of Kintor Pharmaceutical Ltd(KNTPF) is 2024-08-28 Est..
Does Kintor Pharmaceutical Ltd(KNTPF) pay dividends? If so, how much?
Kintor Pharmaceutical Ltd(KNTPF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers